Christian Schank v. Arizona Isotopes Science Research Corp.

CourtCourt of Chancery of Delaware
DecidedOctober 30, 2025
DocketC.A. No. 2025-0208-SEM
StatusPublished

This text of Christian Schank v. Arizona Isotopes Science Research Corp. (Christian Schank v. Arizona Isotopes Science Research Corp.) is published on Counsel Stack Legal Research, covering Court of Chancery of Delaware primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Christian Schank v. Arizona Isotopes Science Research Corp., (Del. Ct. App. 2025).

Opinion

IN THE COURT OF CHANCERY OF THE STATE OF DELAWARE

CHRISTIAN SCHANK, ) CAMERON SCHANK and ) DEANNA MATTHEWS, ) ) Plaintiffs, ) ) v. ) C.A. No. 2025-0208-SEM ) ARIZONA ISOTOPES SCIENCE ) RESEARCH CORPORATION, ) a Delaware corporation, ) ) Defendant. )

Final Post-Trial Report: October 30, 2025 Date Submitted: July 31, 2025

FINAL POST-TRIAL REPORT

Robert L. Burns, Nicole M. Henry, Brendan W. Clark, RICHARDS, LAYTON & FINGER, P.A., Wilmington, DE; Counsel for Plaintiffs.

Richard I.G. Jones, Jr., Periann Doko, Harry W. Shenton, IV, Charmi A. Patel, BERGER MCDERMOTT LLP, Wilmington, DE; Counsel for Defendant.

MOLINA, Senior Magistrate Eschewing a streamlined paper record trial, the parties tried this books and

records action over two nonconsecutive days, calling four witnesses, and introducing

over 300 exhibits. The deep and personal history preceding this action complicated

the matter even further. In several ways, the record before me is reminiscent of my

guardianship and traditional equity docket; a serendipitous, unanticipated overlap.

But the legal issues before me are straightforward. The plaintiffs, stockholders

of the corporate defendant, ask that I order the defendant to disclose additional

information. Specifically, they ask for (1) all records demanded in the operative

demand, (2) removal of certain redactions in documents already produced, (3)

certification when production is complete, and (4) no restrictions on stockholder

communications related thereto. The plaintiffs also argue that the defendant has

engaged in bad faith litigation and fees should be shifted in their favor. The

defendant contends the plaintiffs are the bad faith actors, fees should be shifted in

its favor, and no further production or disclosure is warranted.

For the reasons explained herein, I issue a mixed ruling, requiring limited

production, shifting costs, but declining to shift fees. This is my final report.

I. BACKGROUND

Through this action, Christian Schank, Cameron Schank, and Deanna

Matthews (the “Plaintiffs”) seek to inspect certain books and records of Arizona Isotopes Science Research Corp (the “Defendant”).1 Before addressing the merits of

their request, I provide a brief factual background. The following facts are drawn

from the parties’ stipulations in the pretrial order, 314 exhibits,2 four deposition

transcripts, and testimony presented at our 1.5-day trial held on June 3, 2025 and

June 17, 2025.3

A. The Parties

The Defendant, a “nuclear medicine and radionuclide manufacturing

company specializing in developing and producing medical isotopes and research[,]”

was founded in 2017.4 At its helm, Gregory “Wade” Brooksby serves as president

and chief executive officer, while his father, Brandt Brooksby, serves as chairman

1 The parties’ jointly submitted exhibits are cited as “JX__.” Deposition testimony is cited to as “[First Name] Dep.” I grant the evidence before me the weight and credibility I find it deserves. 2 Although the joint exhibit numbering begins at 1 and ends at 451, there are gaps. The parties submitted, and I admitted, joint exhibits 1 through 192, 200 through 270, and 400 through 451, totaling 314 exhibits. With their post-trial brief, the Plaintiffs submitted an additional document in what they say was “not in an attempt to supplement the trial record, but to alert the Court to what appears to [be] a planned attempt to violate the” stipulated order “postpon[ing] [the 2025 annual meeting] until at least sixty (60) days after the entry of the Court’s final judgment” in this action. Docket Item (“D.I.”) 67 at 22–23 (citing the parties’ stipulated agreement, which I approved (D.I. 29)). The Defendant responded on July 16, 2025, reiterating that it has no intention of violating the stipulated order. Relying on that response, I need not address the issue further. 3 See D.I. 47 (“Pretrial Order”); D.I. 61, 65 (trial transcripts). I cite to the trial transcripts in the form “[First Name] Tr.” 4 Pretrial Order p. 23 ¶ 52; JX2.

2 of its board of directors, and handles the treasury, accounting, and tax matters.5

Leading the Defendant’s research until his passing in 2024 was Clyde Jupiter, a

“world-renowned scientist on nuclear safety[.]”6

The Defendant’s certificate of incorporation, dated September 29, 2017,

authorized it to issue 10,000,000 shares of common stock, and 2,500,000 shares of

preferred stock.7 On the day of incorporation, husband and wife Clyde and Patricia

“Pat” Jupiter (the “Jupiters”) were issued 1,000,000 shares of the Defendant’s

common stock;8 overtime their interests grew and by 2023, the Jupiters owned

1,157,143 shares.9 The record also includes two promissory notes through which the

Defendant promised to repay to the Jupiters $3,200,000 with interest (the “Jupiter

Notes”).10

5 Christian Tr. 22:9–13; Brandt Tr. 235:6–14. Throughout this post-trial decision, I may use first names for clarity and intend to suggest no familiarity or disrespect. 6 Brandt Tr. 240:14–15. There are conflicting views regarding Mr. Jupiter’s role with the Defendant, particularly whether he was a true co-founder, or given that title merely honorarily. Contrast, e.g., JX122 at 3 (Sheldon L. Trubatch, the Defendant’s corporate secretary, referring to Mr. Jupiter as the Defendant’s “founder”), with Brandt Tr. 285:11– 16 (denying that Mr. Jupiter was the Defendant’s co-founder, instead referring to Mr. Jupiter as the Defendant’s “senior scientist”). Differing points aside, Mr. Jupiter clearly was of great value to the Defendant. 7 JX2 at 1. The certificate of incorporation was amended on September 14, 2019, providing only for authorization to issue 10,000,000 common shares (i.e., eliminating the preferred stock). JX2 at 4. 8 JX214 at 5. 9 Brandt Tr. 254:1–256:17; JX172 (showing the Defendant’s stock ledger). 10 JX204; JX205. These notes are not reflected in the Defendant’s financial statements. Brandt Tr. 302:7–9. The Plaintiffs contend the Defendant’s financial statements are not

3 Formalities aside, the Defendant is a bit of a family affair, which has split into

factions: the Brooksby side and the Jupiter side. On the Brooksby side are Wade and

Brandt, the Defendant’s president/CEO and chairman respectively and Wade’s

parents-in-law, George (a/k/a Sam) and Saundra Parker, who were also the

Defendant’s largest investors.11 George has since passed and the Plaintiffs have

questioned the accuracy of how the Parkers’ interests are reflected in the Defendant’s

stock certificates and Saundra Parker’s capacity to vote any remaining shares.12 Per

Christian, the Parkers’ shares are held in trust by the Parkers’ son, Kevin, Mrs.

Parker does not have the authority or capacity to vote, and the Brooksby’s are

exploiting Mrs. Parker’s vulnerabilities.13

Then, on the Jupiter side, there was the Jupiters (recall Mr. Jupiter passed in

2024) and their family, which includes the Plaintiffs. The first plaintiff is Christian

Schank, Mrs. Jupiter’s son and Mr. Jupiter’s stepson. He has held stock in the

accurate because they do not reflect the Jupiter Notes and use this to support their credible basis argument. See D.I. 59 (“Pretrial Conference Tr.”) at 24:22–26:4. Christian testified he was unaware of the Jupiter Notes “at the time the demand letter was made.” Christian Tr. 93:14–15. 11 JX3 (showing 2,000,000 shares issued to George R. and Saundra L. Parker on October 2, 2018); JX4 (showing George R. Parker was a director of the Defendant in August 2019). Before his passing, George also went by “Sam” and “Sammy.” Lisa Tr.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Thomas & Betts Corp. v. Leviton Manufacturing Co.
681 A.2d 1026 (Supreme Court of Delaware, 1996)
Thomas & Betts Corp. v. Leviton Mfg. Co.
685 A.2d 702 (Court of Chancery of Delaware, 1995)
eBay Domestic Holdings, Inc. v. Newmark
16 A.3d 1 (Court of Chancery of Delaware, 2010)
Sanders v. Ohmite Holding, LLC
17 A.3d 1186 (Court of Chancery of Delaware, 2011)

Cite This Page — Counsel Stack

Bluebook (online)
Christian Schank v. Arizona Isotopes Science Research Corp., Counsel Stack Legal Research, https://law.counselstack.com/opinion/christian-schank-v-arizona-isotopes-science-research-corp-delch-2025.